Dosing of Cohort 1 complete with first three patients having received starting dose of JAG201 delivered via intracerebroventricular (ICV) injectionFirst two patients in dose-escalation Cohort 2 have ...
Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.
New research talks about a promising adjunctive treatment to help people to build a life that isn't run by OCD.
Most women experience the effects of menopause firsthand. However, the choice of treatment can be complicated, and research shows both benefits and risks.
A low-dose, single-pill combination proved to be as effective as — and in some cases, superior to — standard-dose monotherapy ...
The device is administered as a swallowable capsule that is filled with liquid by a physician and naturally leaves the body after approximately 4 months.
Luvesilocin is a subcutaneously-administered, proprietary prodrug of the psilocybin-like compound 4-OH-DiPT designed to target the serotonin 2A receptor.
DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...
Two large real-world analyses presented at ACTRIMS Forum 2026 shed new light on the multiple sclerosis (MS) care continuum, ...
Leading Sleep Surgeon Dr. Jordan Weiner Brings Cutting-Edge CPAP Alternative to Arizona Patients Not every state has a ...
Starting biologic therapy at diagnosis, rather than escalating later, may significantly reduce complications and ...
FILSPARI generated $103.3 million in U.S. net product sales for Q4 and $322 million for the full year. Thiola and Thiola EC contributed $23.3 million in U.S. net product sales during Q4 and $88.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results